Clinical Trials Browser

Phase 2 × Unknown × Urethral Neoplasms × Clear all

NCT01118039 2013-08-07

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms, Urethral Neoplasms